본문 바로가기 주메뉴 바로가기
2017 HiVF

2017 HiVF

2017 HiVF Program

Time Contents Speaker Moderator
08:00~09:00 Registration
09:00~09:30 Opening Ceremony
  • - Welcome Speech
  • - Congratulatory Address
09:30~10:00 Overview over vaccines and 2017 HIVF Jun Hee Woo (President, Korean Vaccine Society),
Joon Haeng Rhee (Chair, HIVF)
Session 1. Vaccines for society and industry
Kyu Youn Ahn (Dean, Chonnam National University Medical School)
10:20~11:00 'Roadmap of National Vaccine Research Center of Korea NIH-Linking to Global/National Vaccine Strategies' Youngmee Jee (Director, Center of Infectious Disease Research, Korea NIH)
11:00~11:40 'Past, Present and Future of Vaccine development in Korea' Hyi-Jeong Ji (Director of R&D, Green Cross Corporation, Korea)
11:40~12:20 'Past, Present, and Future of Hepatitis Vaccination in China' Xuanyi Wang (Professor of Shanghai Medical School, Fudan University, China)
12:20~13:20 Lunch
Session 2. Recent progress in vaccines
Jerome Kim (Director General, International Vaccine Institute, Korea)
13:20~14:00 'Broadly Protective/Universal Influenza Vaccines - Enhancing the Standard of Care' Ted M. Ross (Director, Center for Vaccines and Immunology, University of Georgia, USA)
14:00~14:40 Ebola Vaccines Nancy Sullivan (Chief, Biodefense Research Section, Vaccine Research Center, NIH, USA)
14:40~15:20 'Heterologous prime-boost immunizations and a novel irradiation-based inactivation technology for vaccine development' Sebastian Ulbert (Head, Department of Immunology, Fraunhofer Institute for Cell Theraphy and Immunology, Germany)
15:20~15:50 Coffee Break
Session 3. How to make vaccines stronger and safer
Seung Hyun Choi (Director, Mogam Biotechnology Research Institute, Korea)
15:50~16:30 'Designing new generation adjuvants for vaccines and therapeutics' Steven Reed ( President & CEO, Infectious Disease Research Institute, USA)
16:30~17:10 Extracellular nucleic acids in infection, inflammation and vaccination Ken Ishii (Professor, Vaccine and Adjuvant Research Center at NIBIOHN, Japan)
17:10~17:50 'Flagellin as the right partner for vaccines and immunotherapies' Shee Eun Lee(Professor, Clinical Vaccine R&D Center and College of Dentistry, Chonnam National University, Korea)
17:50~18:00 Closing and Farewell

2017 HiVF Speakers

Dr. Nancy Sullivan

Dr. Nancy Sullivan

USA. Chief, Biodefense Research Section, VRC, NIAID, NIH

Learn more

Dr. Nancy Sullivan

Nationality
USA
Affiliation
Chief, Biodefense Research Section, VRC, NIAID, NIH

Worked in collaboration with researchers at the VRC, the U.S Army Medical Research Institute of Infectious Diseases, and Okairos, a Swiss-Italian biotechnology company acquired by GSK in 2013.

Prof. Ken Ishii

Prof. Ken Ishii

Japan. Director, Center for Vaccine and Adjuvant Research (CVAR), National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN)

Learn more

Prof. Ken Ishii

Nationality
Japan
Affiliation
Director, Center for Vaccine and Adjuvant Research (CVAR), National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN)
Project Leader, Lab. of Adjuvant Innovation, Lab. of Mock Up Vaccine, CVAR, NIBIOHN, Osaka, Japan
Professor, Lab. of Vaccine Science, Immunology Frontier Research Center (IFREC), Osaka University

Director, Department of Research Promotion, Japan Agency for Medical Research and Development (AMED), Japan
Senior Resident, Dep. of Anesthesiology School of Medicine, Yokohama City University, Japan

Dr. Steven Reed

Dr. Steven Reed

USA. Professor of Medicine at Cornell University Medical College in New York and Research Professor of Pathobiology at the University of Washington

Learn more

Dr. Steven Reed

Nationality
USA
Affiliation
Professor of Medicine at Cornell University Medical College in New York and Research Professor of Pathobiology at the University of Washington
The Founder, President, and CEO of the Infectious Disease Research Institute (IDRI), based in Seattle, USA

Member of the Tropical Medicine Review Board of the National Institutes of Health
Member of the Vaccine Development Steering Committee of the World Health Organization
Developed the first defined vaccines for leishmaniasis

Dr. Xuan-Yi Wang

Dr. Xuan-Yi Wang

China. Research Scientist Institute of Biomedical Sciences Fudan University

Learn more

Dr. Xuan-Yi Wang

Nationality
China
Affiliation
Research Scientist Institute of Biomedical Sciences Fudan University
Deputy Director at the National Engineering Laboratory for Therapeutic Vaccines, China

Authored 100 articles and book chapters on all aspects of vaccine development and design of clinical trials
Involved in the development and implementation of vaccines for hepatitis A and B, rotavirus, mumps, EV71 and other pathogens

Dr. Sebastian Ulbert

Dr. Sebastian Ulbert

Germany. Fraunhofer Institute for Cell Therapy and Immunology (IZI)

Learn more

Dr. Sebastian Ulbert

Nationality
Germany
Affiliation
Fraunhofer Institute for Cell Therapy and Immunology (IZI)
Head Department of Immunology

EU-project WINGS (vaccines and diagnostics for West Nile virus infections, grant 261426), 2011-2014, coordinator

Dr. Youngmee Jee

Dr. Youngmee Jee

Korea. Director of Center for Infectious Disease Research (CIDR) in the National Institute of Health (NIH)

Learn more

Dr. Youngmee Jee

Nationality
Korea
Affiliation
Director of Center for Infectious Disease Research (CIDR) in the National Institute of Health (NIH)

Led the polio/enterovirus, hepatitis virus and gastroenteritis virus team for laboratory diagnosis, operation of laboratory based-surveillance, and research, development and training in the National Institute of Health, Korea Center for Disease Control (CDC)
Member of the hepatitis B expert resource panel and the Strategic Technical Advisory Committee on Hepatitis in the WHO Western Pacific Region

PhD. Hyi-Jeong Ji

PhD. Hyi-Jeong Ji

Korea. Senior Vice President, Corporate Development Green Cross

Learn more

PhD. Hyi-Jeong Ji

Nationality
Korea
Affiliation
Senior Vice President, Corporate Development Green Cross

Principal Scientist, Biotech, Life Sciences R&D, LG Chem., Ltd.- Vaccine/Biopharmaceutical development
Vice president, Product development, Pharmaceutical Division,
LG Life Sciences, Ltd. (LGLS)

Prof. Lee, Shee Eun

Prof. Lee, Shee Eun

Korea. Professor, Department of Pharmacology and Dental Therapeutics, Chonnam National University School of Dentistry

Learn more

Prof. Lee, Shee Eun

Nationality
Korea
Affiliation
Professor, Department of Pharmacology and Dental Therapeutics, Chonnam National University School of Dentistry

Associate Professor, Department of Pharmacology and Dental Therapeutics, Chonnam National University School of Dentistry